Skip to main content
Have a personal or library account? Click to login
Manifestations of Rheumatic Carditis, Regression of Valvular Regurgitation, and Independent Predictors of Mitral Regurgitation Improvement After Rheumatic Carditis in Thai Children Cover

Manifestations of Rheumatic Carditis, Regression of Valvular Regurgitation, and Independent Predictors of Mitral Regurgitation Improvement After Rheumatic Carditis in Thai Children

Open Access
|Feb 2024

References

  1. Karthikeyan G, Guilherme L. Acute rheumatic fever. The Lancet. 2018; 392(10142): 16174. DOI: 10.1016/S0140-6736(18)30999-1
  2. da Silva TL Jr., Pazin-Filho A, Romano MMD, Ferriani VPL, Marin-Neto JA, Maciel BC, et al. Mitral valve thickening in acute rheumatic fever as a predictor of late valvar dysfunction. PLoS One. 2021; 16(11): e0259737. DOI: 10.1371/journal.pone.0259737
  3. Ralph AP, Currie BJ. Therapeutics for rheumatic fever and rheumatic heart disease. Aust Prescr. 2022; 45(4): 10412. DOI: 10.18773/austprescr.2022.034
  4. Ralph AP, Noonan S, Wade V, Currie BJ. The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. Med J Aust. 2021; 214(5): 2207. DOI: 10.5694/mja2.50851
  5. Ghamari SH, Abbasi-Kangevari M, Saeedi Moghaddam S, Aminorroaya A, Rezaei N, Shobeiri P, et al. Rheumatic Heart Disease Is a Neglected Disease Relative to Its Burden Worldwide: Findings From Global Burden of Disease 2019. J Am Heart Assoc. 2022; 11(13): e025284. DOI: 10.1161/JAHA.122.025284
  6. Arvind B, Ramakrishnan S. Rheumatic Fever and Rheumatic Heart Disease in Children. Indian J Pediatr. 2020; 87(4): 30511. DOI: 10.1007/s12098-019-03128-7
  7. Fabi M, Calicchia M, Palleri D, Ndikubwimana I, Conard C, Rusingiza Kamanzi E, et al. Pediatric rheumatic carditis in Italy and Rwanda: The same disease, different socio-economic settings. Int J Cardiol. 2021; 338: 15460. DOI: 10.1016/j.ijcard.2021.06.027
  8. Yilmazer MM, Oner T, Tavli V, Cilengiroglu OV, Guven B, Mese T, et al. Predictors of chronic valvular disease in patients with rheumatic carditis. Pediatr Cardiol. 2012; 33(2): 23944. DOI: 10.1007/s00246-011-0120-8
  9. Rémond M, Atkinson D, White A, Brown A, Carapetis J, Remenyi B, et al. Are minor echocardiographic changes associated with an increased risk of acute rheumatic fever or progression to rheumatic heart disease? Int J Cardiol. 2015; 198: 11722. DOI: 10.1016/j.ijcard.2015.07.005
  10. de Loizaga SR, Beaton AZ. Rheumatic Fever and Rheumatic Heart Disease in the United States. Pediatr Ann. 2021; 50(3): e98e104. DOI: 10.3928/19382359-20210221-01
  11. Tal R, Hamad Saied M, Zidani R, Levinsky Y, Straussberg R, Amir J, et al. Rheumatic fever in a developed country – is it still relevant? A retrospective, 25 years follow-up. Pediatr Rheumatol Online J. 2022; 20(1): 20. DOI: 10.1186/s12969-022-00678-7
  12. Noubiap JJ, Agbor VN, Bigna JJ, Kaze AD, Nyaga UF, Mayosi BM. Prevalence and progression of rheumatic heart disease: a global systematic review and meta-analysis of population-based echocardiographic studies. Sci Rep. 2019; 9(1): 17022. DOI: 10.1038/s41598-019-53540-4
  13. Breda L, Marzetti V, Gaspari S, Del Torto M, Chiarelli F, Altobelli E. Population-based study of incidence and clinical characteristics of rheumatic fever in Abruzzo, central Italy, 2000–2009. J Pediatr. 2012; 160(5): 8326.e1. DOI: 10.1016/j.jpeds.2011.10.009
  14. Meira ZM, Goulart EM, Colosimo EA, Mota CC. Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart. 2005; 91(8): 101922. DOI: 10.1136/hrt.2004.042762
  15. Yilmazer MM, Oner T, Tavlı V, Cilengiroğlu OV, Güven B, Meşe T, et al. Predictors of chronic valvular disease in patients with rheumatic carditis. Pediatr Cardiol. 2012; 33(2): 23944. DOI: 10.1007/s00246-011-0120-8
  16. Cannon J, Roberts K, Milne C, Carapetis JR. Rheumatic Heart Disease Severity, Progression and Outcomes: A Multi-State Model. J Am Heart Assoc. 2017; 6(3). DOI: 10.1161/JAHA.116.003498
  17. Coffey PM, Ralph AP, Krause VL. The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: A systematic review. PLoS Negl Trop Dis. 2018; 12(6): e0006577. DOI: 10.1371/journal.pntd.0006577
  18. Zühlke L, Karthikeyan G, Engel ME, Rangarajan S, Mackie P, Cupido-Katya Mauff B, et al. Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study). Circulation. 2016; 134(19): 145666. DOI: 10.1161/CIRCULATIONAHA.116.024769
  19. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. Jama. 1992; 268(15): 206973. DOI: 10.1001/jama.268.15.2069
  20. Wilson NJ, Voss L, Morreau J, Stewart J, Lennon D. New Zealand guidelines for the diagnosis of acute rheumatic fever: small increase in the incidence of definite cases compared to the American Heart Association Jones criteria. N Z Med J. 2013; 126(1379): 509.
  21. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003; 16(7): 777802. DOI: 10.1016/S0894-7317(03)00335-3
  22. Pettersen MD, Du W, Skeens ME, Humes RA. Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. J Am Soc Echocardiogr. 2008; 21(8): 92234. DOI: 10.1016/j.echo.2008.02.006
  23. Chaikitpinyo A, Panamonta M, Wongswadiwat Y, Weraarchakul W, Panamonta O, Panthongviriyakul A, et al. Rheumatic and congenital heart diseases among school children of Khon Kaen, Thailand: declining prevalence of rheumatic heart disease. Asian Biomedicine. 2017; 8(5): 64550. DOI: 10.5372/1905-7415.0805.339
  24. Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, et al. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990–2015. N Engl J Med. 2017; 377(8): 71322. DOI: 10.1056/NEJMoa1603693
  25. Sika-Paotonu D, Beaton A, Raghu A, Steer A, Carapetis J. Acute Rheumatic Fever and Rheumatic Heart Disease. In: Ferretti JJ, Stevens DL, Fischetti VA (eds.), Streptococcus pyogenes: Basic Biology to Clinical Manifestations. Oklahoma City, OK: University of Oklahoma Health Sciences Center. 2016; 605647.
  26. Mutagaywa RK, Wind AM, Kamuhabwa A, Cramer MJ, Chillo P, Chamuleau S. Rheumatic heart disease anno 2020: Impacts of gender and migration on epidemiology and management. Eur J Clin Invest. 2020; 50(12): e13374. DOI: 10.1111/eci.13374
  27. Patel FR, Tan JW, Rao S. Acute rheumatic fever in the paediatric population: a descriptive study in the Malaysian state of Sabah. Cardiol Young. 2022; 32(1): 837. DOI: 10.1017/S1047951121001621
  28. Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol. 2011; 3: 6784. DOI: 10.2147/CLEP.S12977
  29. Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev. 2002; 2002(3): CD002227. DOI: 10.1002/14651858.CD002227
  30. de Loizaga SR, Arthur L, Arya B, Beckman B, Belay W, Brokamp C, et al. Rheumatic Heart Disease in the United States: Forgotten But Not Gone: Results of a 10 Year Multicenter Review. J Am Heart Assoc. 2021; 10(16): e020992. DOI: 10.1161/JAHA.120.020992
  31. Narin N, Mutlu F, Argun M, Ozyurt A, Pamukcu O, Baykan A, et al. Incidence and clinical features of acute rheumatic fever in Kayseri, Central Anatolia, 1998–2011. Cardiol Young. 2015; 25(4): 74551. DOI: 10.1017/S1047951114000900
  32. Veasy LG, Tani LY, Hill HR. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr. 1994; 124(1): 916. DOI: 10.1016/S0022-3476(94)70247-0
  33. Voss LM, Wilson NJ, Neutze JM, Whitlock RM, Ameratunga RV, Cairns LM, et al. Intravenous immunoglobulin in acute rheumatic fever: a randomized controlled trial. Circulation. 2001; 103(3): 4016. DOI: 10.1161/01.CIR.103.3.401
  34. The natural history of rheumatic fever and rheumatic heart disease. Ten-year report of a cooperative clinical trial of ACTH, cortisone, and aspirin. Circulation. 1965; 32(3): 45776. DOI: 10.1161/01.CIR.32.3.457
  35. Lumngwena EN, Skatulla S, Blackburn JM, Ntusi NAB. Mechanistic implications of altered protein expression in rheumatic heart disease. Heart Fail Rev. 2022; 27(1): 35768. DOI: 10.1007/s10741-020-09993-1
  36. Vasan RS, Shrivastava S, Vijayakumar M, Narang R, Lister BC, Narula J. Echocardiographic evaluation of patients with acute rheumatic fever and rheumatic carditis. Circulation. 1996; 94(1): 7382. DOI: 10.1161/01.CIR.94.1.73
  37. Essop MR, Wisenbaugh T, Sareli P. Evidence against a myocardial factor as the cause of left ventricular dilation in active rheumatic carditis. Journal of the American College of Cardiology. 1993; 22(3): 8269. DOI: 10.1016/0735-1097(93)90197-9
DOI: https://doi.org/10.5334/gh.1295 | Journal eISSN: 2211-8179
Language: English
Submitted on: Mar 31, 2023
Accepted on: Jan 12, 2024
Published on: Feb 7, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2024 Araya Kaewpechsanguan, Paweena Chungsomprasong, Kritvikrom Durongpisitkul, Chodchanok Vijarnsorn, Prakul Chanthong, Supaluck Kanjanauthai, Thita Pacharapakornpong, Ploy Thammasate, Jarupim Soongswang, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.